JBJacques Bienvenu

Jacques Bienvenu

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Jacques Bienvenu has a total of 8 co-authors. Here are the top co-authors by number of shared publications:

  • Christian Isaac

    Immunology Laboratory, Centre Hospitalier Lyon Sud, 69495 Pierre-Bénite, France

    1 shared publication
  • Françoise Bienvenu

    Laboratory of Clinical Chemistry, Hôpital Debrousse, 69322 Lyon Cedex 05, France

    1 shared publication
  • G Monneret

    Laboratoire d'Immunologie, Centre Hospitalier Lyon-Sud, France

    1 shared publication
  • Guillaume Monneret

    Immunology Laboratory, Centre Hospitalier Lyon Sud, 69495 Pierre-Bénite, France

    1 shared publication
  • Guy Putet

    Department of Neonatology, Hôpital Debrousse, 69322 Lyon Cedex 05, France

    1 shared publication
  • Jean Marc Labaune

    Department of Neonatology, Hôpital Debrousse, 69322 Lyon Cedex 05, France

    1 shared publication

Latest Publications

  • Open Access

    Usefulness of Procalcitonin in Neonates at Risk for Infection

    by Tanguy Martin-Denavit, Guillaume Monneret, Jean Marc Labaune, Christian Isaac, Françoise Bienvenu, Guy Putet, Jacques Bienvenu

    We are very interested in the report by Sachse et al. (1) on procalcitonin (PCT) variations in the neonatal period. This report confirms and extends previous work on the daily variations of PCT during the first days of life in noninfected newborn infants (2)(3). We agree that PCT could be a useful marker for the presence, course, and prognosis of bacterial infection, particularly in newborns hospitalized with a risk factor for infection (such as an increase in the mother’s body temperature during delivery, premature rupture of membranes, vaginal colonization by group B streptococcus, and other factors). In this context, prophylactic antibiotic therapy is started during labor and if clinical signs of infection are present at delivery, antibiotics are continued. Thus, the diagnosis of infection cannot be confirmed by culture because this preventive therapy is responsible for the negativity of bacteriological tests (blood and cerebrospinal fluid cultures).


  • Detection of allergen-induced basophil activation by expression of CD63 antigen using a tricolour flow cytometric method

    by G Monneret, M C Gutowski, J Bienvenu

    In the field of allergy diagnosis, most in vitro functional tests are focused on basophils. Nevertheless, the very small number of circulating basophils limits these experiments and their clinical benefit remains controversial. As flow cytometry is a valuable tool for identifying cell populations, even at low concentrations, we developed a tricolour flow cytometric method for the study of allergen-induced basophil activation. Identification of cells was based both on CD45 expression and on the presence of IgE on the cell surface, since basophils express high-affinity receptors for IgE (FcεRI). Cell activation upon allergen challenge was assessed by the expression of CD63 antigen on the plasma membrane. Basophil isolation and activation (with the chemotactic peptide formyl-methionyl-leucyl-phenylalanine) were validated in 32 non-allergic patients. In 12 allergic patients, basophil stimulation by a relevant allergen was in most cases positive (10/12). Furthermore a concentration-dependent hook effect was observed. Of the allergic and non-allergic patients, none showed non-specific activation with an irrelevant allergen (specificity 100%). Overall, our preliminary results, even in a small population, suggest that this is a reliable and valuable method for the diagnosis of allergies complementing specific allergen IgE and skin test results. Obviously, additional clinical studies are needed to validate these first results.